Pre-S Deletion and Complex Mutations of Hepatitis B Virus Related to Advanced Liver Disease in HBeAg-Negative Patients
Chien‐Hung Chen(Kaohsiung Chang Gung Memorial Hospital), Chi‐Sin Changchien(Kaohsiung Chang Gung Memorial Hospital), Tsung‐Hui Hu(National Sun Yat-sen University), Chuan–Mo Lee(Chang Gung University), Chao‐Hung Hung(Kaohsiung Chang Gung Memorial Hospital), Jyh–Chwan Wang(Kaohsiung Chang Gung Memorial Hospital), Jing‐Houng Wang(Kaohsiung Chang Gung Memorial Hospital), Sheng‐Nan Lu(Kaohsiung Chang Gung Memorial Hospital)
Cited by 232
Related Papers
Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
|Journal of Clinical Oncology|2013|775
Metabolic Factors and Risk of Hepatocellular Carcinoma by Chronic Hepatitis B/C Infection: A Follow-up Study in Taiwan
|Gastroenterology|2008|547
Hepatogastroenterology
|Hepatogastroenterology|2012|536